《Pharmacology Research & Perspectives》是一本由Wiley-Blackwell出版商出版的专业医学期刊，该刊创刊于2013年，刊期6 issues/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 4区，小类学科：药学 4区；在JCR（Journal Citation Reports）分区等级为Q3。该刊发文范围涵盖药学等领域，旨在及时、准确、全面地报道国内外药学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为2.963，平均审稿速度20 Weeks。

Pharmacology Research & Perspectives英文介绍

PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS

Pharmacology Research & Perspectives中科院分区

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	4区	PHARMACOLOGY & PHARMACY 药学	4区	否	否

Pharmacology Research & Perspectives期刊近9年JCR分区变化趋势

Pharmacology Research & PerspectivesJCR分区(JCR2021-2022年分区)

JCR分区等级	JCR所属学科	分区	影响因子
Q3	PHARMACOLOGY & PHARMACY	Q3	2.963

Pharmacology Research & Perspectives期刊近7年影响因子变化趋势

Pharmacology Research & Perspectives期刊的CiteScore值(CiteScore2021-2022年CiteScore值)

CiteScore	SJR	SNIP	学科类别	分区	排名	百分位
3.30	0.851	0.818	大类：Pharmacology, Toxicology and Pharmaceutics 小类：General Pharmacology, Toxicology and Pharmaceutics	Q2	25 / 74	66%
3.30	0.851	0.818	大类：Pharmacology, Toxicology and Pharmaceutics 小类：Neurology	Q3	94 / 170	45%

Pharmacology Research & Perspectives期刊近7年自引率变化趋势

上周TOP10